Abstract
We present a case of foscarnet ( FOS ) resistance arising from a UL 54 mutation after a short duration of FOS exposure, which has not been previously described in a stem cell transplant recipient, to our knowledge. We discuss the use of FOS to treat other viral infections and the implications this may have for the development of resistance mutations and treatment of cytomegalovirus disease

This publication has 21 references indexed in Scilit: